Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT03543358
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2018-05-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Long-Term Study of Rovalpituzumab Tesirine
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-21
First Submit QC Date:
None
Study First Post Date:
2018-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-11-11
Results First Submit QC Date:
None
Results First Post Date:
2021-01-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-10
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL